Adjuvant Capital

@adjcap

Adjuvant Capital is the leading life sciences investment fund focused on global public health

New York City & San Francisco
Vrijeme pridruživanja: listopad 2018.

Tweetovi

Blokirali ste korisnika/cu @adjcap

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @adjcap

  1. proslijedio/la je Tweet
    16. sij

    Michael Chang of remarks that the antibiotics space lacks a procurement agency like , but could benefit from subscription-like mechanisms for access.

    Poništi
  2. proslijedio/la je Tweet
    16. sij

    is investigating population-based payments that create strong incentives for the development, availability, and appropriate use of priority antibiotics, and better reflect the value effective antibiotics provide

    Poništi
  3. proslijedio/la je Tweet
    14. sij

    "Software is eating the way we make vaccines" 🖥️🍽️💉 Kudos to investees and for leveraging next-generation technologies to test new vaccination approaches.

    Poništi
  4. 14. sij
    Poništi
  5. proslijedio/la je Tweet
    13. sij

    Sometimes sub-optimal = best??? 🤯🤔🤯 When it comes to live attenuated vaccines and oncolytics, we certainly hope so, and just placed a big bet on 's codon de-optimization technology by leading their $20 million Series B.

    Poništi
  6. proslijedio/la je Tweet
    13. sij

    Thrilled to announce our investment in to support the development of their computational + synthetic biology platform for "rational" vaccine design. Onward!

    Poništi
  7. 13. sij
    Poništi
  8. 21. stu 2019.

    Announcing our investment in the formation of AN2 Therapeutics to tackle infectious diseases, including Melioidosis, a deadly neglected tropical disease endemic to SE Asia.

    Poništi
  9. proslijedio/la je Tweet
    5. stu 2019.

    Latest issue of Field Notes from (w/⁦⁩) is out!

    Poništi
  10. proslijedio/la je Tweet
    4. lis 2019.

    Our sincerest thanks to for the innovative financing provided to support ! ### "These diseases pose an increasing threat to humanity, yet the field remains under-invested. It will be a major war and the battle has just begun.” -EIB DG Jean-Christophe Laloux

    Poništi
  11. 3. lis 2019.
    Poništi
  12. proslijedio/la je Tweet
    30. ruj 2019.

    Check out the latest edition of Field Notes for a taste of what the team has been reading and discussing the last few weeks!

    Poništi
  13. 30. ruj 2019.

    This week's Field Notes is live. Check out what the Adjuvant team is reading and discussing this week!

    Poništi
  14. proslijedio/la je Tweet
    30. ruj 2019.

    Check out our latest Field Notes for a taste of what the team has been reading the last few weeks!

    Poništi
  15. proslijedio/la je Tweet
    26. ruj 2019.

    What is the world's deadliest animal? It's not sharks, nor alligators or humans – it's mosquitoes. In our latest guest article, read how investors like are stepping up in the fight against mosquito-transmitted diseases

    Poništi
  16. 23. ruj 2019.

    “I wish I could say everyone has jumped on the bandwagon. For global health, it isn’t true.” - Jenny Yip, General Partner at Adjuvant Capital featured in

    Poništi
  17. proslijedio/la je Tweet
    23. ruj 2019.

    Wow. at absolutely nailed it 👏✅ with her story about , , , , , and the work we are all doing to fund new technologies for major public health challenges. ###

    Poništi
  18. proslijedio/la je Tweet
    18. ruj 2019.

    Excited to announce that participated in 's Series D alongside Farallon Capital, Hadean Ventures and Merck to support the company’s Phase 3 study for its Chikungunya vaccine. Never heard of Chikungunya virus? Ask me about it!

    Poništi
  19. 18. ruj 2019.

    Thrilled to be joined by , Farallon Capital, and Hadean Ventures, along with existing partners and , on the journey!

    Poništi
  20. proslijedio/la je Tweet
    10. ruj 2019.

    In a move that should make sheep around the world rejoice 🙌, we are pleased to share that has committed $7m to help InDevR commercialize its multiplexed protein quantification technology and expand the menu of biologics that can be characterized.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·